Radiological semantics discriminate clinically significant grade prostate cancer

[1] Siegel RL(2018)Cancer statistics, 2018 CA Cancer J Clin 68 7-30

[2] Miller KD(2009)Screening and prostate-cancer mortality in a randomized European study New Engl J Med 360 1320-383

[3] Jemal A(2009)Lead time and Overdiagnosis in prostate-specific antigen screening: importance of methods and context Yearbook Urol 101 374-2800

[4] Schröder FH(2011)Changes in prostate cancer grade on serial biopsy in men undergoing active surveillance J Clin Oncol 29 2795-1022

[5] Hugosson J(2017)Precision of MRI/ultrasound-fusion biopsy in prostate cancer diagnosis: an ex vivo comparison of alternative biopsy techniques on prostate phantoms World J Urol 35 1015-397

[6] Roobol MJ(2015)Comparison of MR/ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer Jama 313 390-494

[7] Draisma G(2011)Magnetic resonance imaging for the detection, localisation, and characterisation of prostate cancer: recommendations from a European consensus meeting Eur Urol 59 477-497

[8] Etzioni R(2011)Consensus criteria for the use of magnetic resonance imaging in the diagnosis and staging of prostate cancer: not ready for routine use Eur Urol 59 495-W9

[9] Tsodikov A(2017)PI-RADS version 2: detection of clinically significant cancer in patients with biopsy Gleason score 6 prostate cancer Am J Roentgenol 209 W1-19

[10] Porten SP(2015)Detection of clinically significant prostate cancer using magnetic resonance imaging-ultrasound fusion targeted biopsy: a systematic review Eur Urol 68 8-562

[1] Siegel RL(2018)Cancer statistics, 2018 CA Cancer J Clin 68 7-30

[2] Miller KD(2009)Screening and prostate-cancer mortality in a randomized European study New Engl J Med 360 1320-383

[3] Jemal A(2009)Lead time and Overdiagnosis in prostate-specific antigen screening: importance of methods and context Yearbook Urol 101 374-2800

[4] Schröder FH(2011)Changes in prostate cancer grade on serial biopsy in men undergoing active surveillance J Clin Oncol 29 2795-1022

[5] Hugosson J(2017)Precision of MRI/ultrasound-fusion biopsy in prostate cancer diagnosis: an ex vivo comparison of alternative biopsy techniques on prostate phantoms World J Urol 35 1015-397

[6] Roobol MJ(2015)Comparison of MR/ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer Jama 313 390-494

[7] Draisma G(2011)Magnetic resonance imaging for the detection, localisation, and characterisation of prostate cancer: recommendations from a European consensus meeting Eur Urol 59 477-497

[8] Etzioni R(2011)Consensus criteria for the use of magnetic resonance imaging in the diagnosis and staging of prostate cancer: not ready for routine use Eur Urol 59 495-W9

[9] Tsodikov A(2017)PI-RADS version 2: detection of clinically significant cancer in patients with biopsy Gleason score 6 prostate cancer Am J Roentgenol 209 W1-19

[10] Porten SP(2015)Detection of clinically significant prostate cancer using magnetic resonance imaging-ultrasound fusion targeted biopsy: a systematic review Eur Urol 68 8-562